| Structure | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 InChI=1S/C21H29N9O/c1-2-6-24-19-17(20-29-28-18(31-20)15-30-12-10-23-11-13-30)14-26-21(27-19)25-9-5-16-3-7-22-8-4-16/h3-4,7-8,14,23H,2,5-6,9-13,15H2,1H3,(H2,24,25,26,27) |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 193.736 | 30932474 | | DeepCCS | [M-H]- | 191.378 | 30932474 | | DeepCCS | [M-2H]- | 225.576 | 30932474 | | DeepCCS | [M+Na]+ | 200.804 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 2.6 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.6849 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.28 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 478.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 165.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 108.2 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 146.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 55.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 265.8 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 345.4 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 703.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 623.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 61.0 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 862.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 180.7 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 217.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 440.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 475.7 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 264.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatized| Metabolite | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 4198.1 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3679.0 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)- | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3983.9 | Semi standard non polar | 33892256 |
Derivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3682.8 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3725.8 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 5488.9 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3685.0 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3733.6 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 5449.2 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3815.7 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3798.9 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 5544.7 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3625.8 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 3498.0 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C | 5162.3 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3746.8 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3723.1 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 5299.1 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3765.0 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 3726.7 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1 | 5247.2 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3744.9 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 3519.4 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C)CC2)O1)[Si](C)(C)C | 4963.6 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3845.6 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3916.9 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #1 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 5535.2 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3853.2 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 3922.6 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #2 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1 | 5474.3 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 4025.6 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 3988.4 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,1TBDMS,isomer #3 | CCCNC1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 5662.5 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3943.8 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 3910.4 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCNCC2)O1)[Si](C)(C)C(C)(C)C | 5180.8 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4085.0 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4076.7 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #2 | CCCN(C1=NC(NCCC2=CC=NC=C2)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 5412.1 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 4121.3 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 4077.1 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,2TBDMS,isomer #3 | CCCNC1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1 | 5336.9 | Standard polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4240.9 | Semi standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 4112.4 | Standard non polar | 33892256 | | 2,4-Pyrimidinediamine, 5-(5-(1-piperazinylmethyl)-1,3,4-oxadiazol-2-yl)-N4-propyl-N2-(2-(4-pyridinyl)ethyl)-,3TBDMS,isomer #1 | CCCN(C1=NC(N(CCC2=CC=NC=C2)[Si](C)(C)C(C)(C)C)=NC=C1C1=NN=C(CN2CCN([Si](C)(C)C(C)(C)C)CC2)O1)[Si](C)(C)C(C)(C)C | 5071.0 | Standard polar | 33892256 |
|
|---|